减少心血管疾病的不平等:关注边缘化人口,考虑种族和种族
Sonia S Anand1,2,3,4, Sujane Kandasamy2,4,5, Miles Marchand6,7
1Chanchlani Research Centre, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
The Lancet regional health. Europe
|November 7, 2025
概括
心血管疾病 (CVD) 不成比例地影响边缘化群体,原因是医疗保健接入障碍. 标准化数据收集和有针对性的策略对于改善心血管健康公平至关重要.
科学领域:
- 公共卫生 公共卫生
- 心血管医学 心血管医学
- 健康 公平 研究 健康 公平 研究
背景情况:
- 心血管疾病 (CVD) 患病率和风险因素在边缘化种族,种族和土著人口中更高.
- 这些群体在获得心血管医疗保健方面遇到重大障碍,扩大了健康公平差距.
- 尽管已经建立起了医疗保健系统,但在欧洲和北美存在着心血管健康结果的持续和不断扩大的差异.
研究的目的:
- 审查基于种族,种族,祖先和土著的冠心病和中风的差异.
- 检查这些因素与欧洲和北美的性别,性别和社会经济地位 (SES) 的交叉关系.
- 提出建议,以解决边缘化人口中心血管健康不平等的问题.
主要方法:
- 专家对有关心血管健康不平等现有知识的专家评价.
- 考虑种族,种族,祖先,土著,性别,性别和SES的差异分析.
- 专注于欧洲和北美的医疗保健系统.
主要成果:
- 建议在卫生行政数据库中对种族和种族进行标准化测量.
- 针对性卫生计划需要识别高风险群体.
- 证据表明,在边缘化的人群中,心血管疾病差异持续和不断扩大.
结论:
- 改善高风险社区的医疗保健准入和研究是必不可少的.
- 促进边缘化社区与公共卫生服务提供者之间的信任至关重要.
- 加强以证据为基础的CVD预防和治疗提供是必要的,以促进健康公平.
相关概念视频
Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Stereotypes, Prejudice, and Discrimination
94.8K
Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
94.8K
Coronary Artery Disease I: Introduction
863
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863
Coronary Artery Disease IV: Preventive Measures
578
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
578
Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K
Peripheral Artery Disease III: Interprofessional Care
231
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
231


